Johnson Investment Counsel’s Cymabay Therapeutics CBAY Stock Holding History

Johnson Investment Counsel’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,000	Closed	-$197K	–	716
2023 Q2	$197K	Hold	18,000	–	–	﹤0.01%	642
2023 Q1	$157K	Hold	18,000	–	–	﹤0.01%	640
2022 Q4	$113K	Hold	18,000	–	–	﹤0.01%	645
2022 Q3	$63K	Hold	18,000	–	–	﹤0.01%	638
2022 Q2	$53K	Hold	18,000	–	–	﹤0.01%	644
2022 Q1	$56K	Hold	18,000	–	–	﹤0.01%	664
2021 Q4	$61K	Hold	18,000	–	–	﹤0.01%	663
2021 Q3	$66K	Hold	18,000	–	–	﹤0.01%	646
2021 Q2	$78K	Hold	18,000	–	–	﹤0.01%	628
2021 Q1	$82K	Hold	18,000	–	–	﹤0.01%	596
2020 Q4	$103K	Buy	+18,000	New	+$136K	﹤0.01%	582

Other funds holding CBAY

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return